Opioid Decisions That Killed 500000
25 guides found.
Opioid Decisions That Killed 500000: 25 2022 Supreme Court blocked immunity deal Sacklers negotiated again retained most of their wealth
THE ONE FACT THEY WON’T FORGET In August 2023, the U.S. Supreme Court blocked a bankruptcy deal that would have granted the Sackler family—owners of Purdue Pharma—permanent legal i…
Opioid Decisions That Killed 500000: 24 2021 Purdue bankruptcy settlement Sacklers paid 45 billion received immunity from civil lawsuits
THE ONE FACT THEY WON’T FORGET In September 2021, the Sackler family—owners of Purdue Pharma, the company that aggressively marketed OxyContin while downplaying its addictive risks…
Opioid Decisions That Killed 500000: 23 2019 Sackler family took 10-12 billion out of Purdue before bankruptcy filing
THE ONE FACT THEY WON’T FORGET Between 2008 and 2019, the Sackler family extracted $10.4 billion from Purdue Pharma—maker of OxyContin—through dividends, bonuses, and offshore tran…
Opioid Decisions That Killed 500000: 22 2017 Trump declared opioid crisis a public health emergency allocated 57000 less than two overdose d
THE ONE FACT THEY WON’T FORGET On October 26, 2017, U.S. President Donald Trump declared the opioid crisis a “public health emergency” under the Public Health Service Act. The same…
Opioid Decisions That Killed 500000: 21 2016 CDC issued prescribing guidelines voluntary not mandatory pharmaceutical lobby had them weakene
THE ONE FACT THEY WON’T FORGET In March 2016, the U.S. Centers for Disease Control and Prevention (CDC) issued voluntary guidelines to curb opioid prescribing—guidelines that were …
Opioid Decisions That Killed 500000: 20 2014 heroin deaths surpassed prescription opioid deaths as reformulation pushed users to street drug
THE ONE FACT THEY WON’T FORGET In 2014, for the first time in U.S. history, heroin deaths surpassed prescription opioid deaths—10,574 to 10,561—while the year before, the Drug Enfo…
Opioid Decisions That Killed 500000: 19 2013 CDC began tracking opioid overdose deaths found 16000 annual prescription opioid deaths
THE ONE FACT THEY WON’T FORGET In 2013, the U.S. Centers for Disease Control and Prevention (CDC) began tracking opioid overdose deaths and found 16,235 annual fatalities from pres…
Opioid Decisions That Killed 500000: 18 2012 259 million opioid prescriptions written enough for every American adult to have a bottle
THE ONE FACT THEY WON’T FORGET In 2012, U.S. pharmacies filled 259 million opioid prescriptions—enough for every adult in the country to have a one-month supply of hydrocodone. Tha…
Opioid Decisions That Killed 500000: 17 2010 McKinsey advised Purdue to counter the narrative around OxyContins risks with more aggressive m
THE ONE FACT THEY WON’T FORGET In June 2010, McKinsey & Company advised Purdue Pharma to counter the growing public narrative about OxyContin’s addiction risks by “turbochargin…
Opioid Decisions That Killed 500000: 16 2010 OxyContin reformulated to abuse-deterrent form users switched to heroin overdose deaths acceler
THE ONE FACT THEY WON’T FORGET In August 2010, Purdue Pharma reformulated OxyContin to make it harder to crush or dissolve—yet within two years, the company’s own internal research…
Opioid Decisions That Killed 500000: 15 2008 prescription opioid deaths exceeded car accident deaths for first time in American history
THE ONE FACT THEY WON’T FORGET In 2008, for the first time in American history, more people died from prescription opioid overdoses than in car accidents. The Centers for Disease C…
Opioid Decisions That Killed 500000: 14 2007 Purdue pleaded guilty to misbranding paid 634 million no senior executives went to prison
THE ONE FACT THEY WON’T FORGET In 2007, Purdue Pharma pleaded guilty to a federal felony for misbranding OxyContin as less addictive than other opioids—a claim its own internal res…
Opioid Decisions That Killed 500000: 13 2006 West Virginia sued Purdue internal documents revealed state settled for 10 million
THE ONE FACT THEY WON’T FORGET In 2001, Purdue Pharma’s internal marketing documents instructed sales representatives to target West Virginia physicians who were already prescribin…
Opioid Decisions That Killed 500000: 12 2004 OxyContin reformulation to abuse-deterrent version delayed 7 years after Purdue knew of abuse p
THE ONE FACT THEY WON’T FORGET In 1997—seven years before Purdue Pharma reformulated OxyContin to deter abuse—Purdue’s own medical director, Dr. J. David Haddox, wrote an internal …
Opioid Decisions That Killed 500000: 11 2002 FDA approved OxyContin for moderate pain expanding market from severe to routine pain managemen
THE ONE FACT THEY WON’T FORGET On May 22, 2002, the U.S. Food and Drug Administration (FDA) approved a new label for OxyContin, expanding its approved use from severe pain to moder…
Opioid Decisions That Killed 500000: 10 2001 DEA and Purdue reached agreement that allowed continued high production quotas
THE ONE FACT THEY WON’T FORGET In April 2001, the U.S. Drug Enforcement Administration (DEA) and Purdue Pharma reached a confidential agreement that allowed the company to maintain…
Opioid Decisions That Killed 500000: 09 2000 Purdue sales representatives made 935000 calls on physicians prescription rates doubled
THE ONE FACT THEY WON’T FORGET In 2000, Purdue Pharma’s sales representatives made 935,000 calls to physicians in the United States—one for every 32 adults prescribed an opioid tha…
Opioid Decisions That Killed 500000: 08 1998 Purdue distributed 15000 copies of a video called I Got My Life Back to doctors
THE ONE FACT THEY WON’T FORGET In 1998, Purdue Pharma mailed 15,000 copies of a promotional video titled I Got My Life Back to physicians across the United States. The film feature…
Opioid Decisions That Killed 500000: 07 1997 Purdue began funding pain advocacy groups that lobbied for fewer opioid restrictions
THE ONE FACT THEY WON'T FORGET In 1997, Purdue Pharma began funding the American Pain Society (APS) and the American Academy of Pain Medicine (AAPM) to the tune of $1.6 million ove…
Opioid Decisions That Killed 500000: 06 1996 OxyContin launched with aggressive sales force targeting primary care physicians not pain speci
THE ONE FACT THEY WON’T FORGET In 1996, Purdue Pharma’s sales representatives were instructed to target primary care physicians—not pain specialists—with a script that described Ox…